Company Name:Acceleron Pharma, Inc.
CEO: Habib J. Dable

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.


Key numbers

Market Capitalization:5901816120
Shares Outstanding: 58689500
Float: 50282053
Next Earning Date:2020-08-06
TTm EPS: -2.5956
TTm Dividend Rate:
200 days moving average:77.46
50 days moving average: 99.43
One day percent Change: -1.63



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,